Feng Li

9.2k total citations · 3 hit papers
402 papers, 6.4k citations indexed

About

Feng Li is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Feng Li has authored 402 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 108 papers in Surgery and 82 papers in Oncology. Recurrent topics in Feng Li's work include Spine and Intervertebral Disc Pathology (43 papers), Bone Metabolism and Diseases (38 papers) and Sarcoma Diagnosis and Treatment (22 papers). Feng Li is often cited by papers focused on Spine and Intervertebral Disc Pathology (43 papers), Bone Metabolism and Diseases (38 papers) and Sarcoma Diagnosis and Treatment (22 papers). Feng Li collaborates with scholars based in China, United States and Japan. Feng Li's co-authors include Hanfeng Guan, Honglei Kang, Yimin Dong, Zhong Fang, Renpeng Peng, Anmin Chen, Shian Hu, Pengju Wang, Wei Xiong and Kehan Song and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Feng Li

376 papers receiving 6.3k citations

Hit Papers

Spinal Cord Injury: The G... 2022 2026 2023 2024 2022 2022 2024 50 100 150 200

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Feng Li 2.0k 1.5k 1.0k 875 763 402 6.4k
Dong Chen 2.5k 1.3× 1.4k 0.9× 1.3k 1.3× 1.1k 1.3× 1.3k 1.6× 528 9.7k
Hwa–Young Son 1.5k 0.8× 1.6k 1.1× 900 0.9× 475 0.5× 354 0.5× 315 7.0k
Sun‐Young Lee 2.1k 1.0× 1.7k 1.1× 967 1.0× 463 0.5× 365 0.5× 315 7.4k
Tetsuya Yamamoto 1.6k 0.8× 1.2k 0.8× 1.0k 1.0× 625 0.7× 348 0.5× 329 6.4k
Albert A. Rizvanov 3.3k 1.7× 763 0.5× 1.2k 1.2× 757 0.9× 697 0.9× 473 8.4k
Yan Zhang 2.4k 1.2× 1.3k 0.9× 794 0.8× 290 0.3× 1.0k 1.3× 500 8.1k
Jin Kim 3.8k 2.0× 1.2k 0.8× 826 0.8× 462 0.5× 770 1.0× 313 9.8k
Jing Wang 1.7k 0.9× 1.3k 0.8× 837 0.8× 845 1.0× 271 0.4× 338 5.5k
Yingying Xu 2.9k 1.5× 1.1k 0.7× 1.7k 1.6× 562 0.6× 1.3k 1.7× 409 8.4k
Jing Nie 3.1k 1.6× 668 0.4× 563 0.6× 425 0.5× 1.0k 1.3× 255 7.8k

Countries citing papers authored by Feng Li

Since Specialization
Citations

This map shows the geographic impact of Feng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Li more than expected).

Fields of papers citing papers by Feng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Li. The network helps show where Feng Li may publish in the future.

Co-authorship network of co-authors of Feng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Li. A scholar is included among the top collaborators of Feng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Li. Feng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Feng, et al.. (2025). Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications. International Journal of Biological Sciences. 21(11). 4762–4781. 1 indexed citations
2.
Li, Feng, et al.. (2025). Multiscale impacts of landscape metrics on water quality based on fine-grained land use maps. Frontiers in Environmental Science. 13.
3.
Huang, Yan, Kexin Sun, Jing Xu, et al.. (2024). Study of the mechanism of acupuncture and moxibustion in protecting the intestinal mucosal barrier in DSS-induced UC rats based on the IL-9/IL-9R pathway. Journal of Acupuncture and Tuina Science. 22(2). 91–103. 1 indexed citations
4.
Wang, Huanxin, Jingxuan Liu, Yonghui Zhang, et al.. (2024). Engineering of Au nanoparticles over hollow MoS2/C nanoreactor for enhanced TEA sensing at low temperature. Vacuum. 224. 113114–113114. 7 indexed citations
5.
6.
Ding, Jiaji, Xiaoliang Sunney Xie, Xinyi Zhang, et al.. (2024). Identification and characterization of novel D-lyxose isomerases from the goat rumen metagenome. Process Biochemistry. 149. 213–221.
7.
Ben, Shuai, Junyi Xin, Feng Li, et al.. (2024). piRNA PROPER Suppresses DUSP1 Translation by Targeting N6‐Methyladenosine‐Mediated RNA Circularization to Promote Oncogenesis of Prostate Cancer. Advanced Science. 11(33). e2402954–e2402954. 12 indexed citations
8.
Li, Guanghui, et al.. (2023). Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence. Osteoporosis International. 35(4). 659–668. 2 indexed citations
9.
Li, Feng, et al.. (2023). Role of the SLIT-ROBO signaling pathway in renal pathophysiology and various renal diseases. Frontiers in Physiology. 14. 1226341–1226341. 3 indexed citations
10.
Li, Feng, Zhongyong Chen, Shengguo Xia, et al.. (2023). Development of electromagnetic pellet injector for disruption mitigation of tokamak plasma. Chinese Physics B. 32(7). 75205–75205. 1 indexed citations
11.
Li, Feng, Junxiang Li, Runhua Chen, et al.. (2022). Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 3 indexed citations
12.
Li, Feng, et al.. (2022). Maternal nutrition altered embryonic MYOD1, MYF5, and MYF6 gene expression in genetically fat and lean lines of chickens. Animal Bioscience. 35(8). 1223–1234. 6 indexed citations
13.
Guo, Qian, Honglei Kang, Jia Wang, et al.. (2020). Inhibition of ACLY Leads to Suppression of Osteoclast Differentiation and Function Via Regulation of Histone Acetylation. Journal of Bone and Mineral Research. 36(10). 2065–2080. 41 indexed citations
14.
Zhang, Zheng, Qian Xu, Chao Song, et al.. (2019). Serum- and Glucocorticoid-inducible Kinase 1 is Essential for Osteoclastogenesis and Promotes Breast Cancer Bone Metastasis. Molecular Cancer Therapeutics. 19(2). 650–660. 23 indexed citations
15.
Song, Mengjia, Ping Yü, Kai Zhang, et al.. (2019). Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer. Cancer Research. 79(14). 3737–3748. 113 indexed citations
16.
Hertz, Daniel L., Kelley M. Kidwell, Feng Li, et al.. (2018). Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy. Clinical Cancer Research. 24(15). 3602–3610. 45 indexed citations
17.
Han, Meihua, Xiaoyu Qi, Yijing Li, et al.. (2018). Administration of raloxifene hydrochloride nanosuspensions partially attenuates bone loss in ovariectomized mice. RSC Advances. 8(42). 23748–23756. 3 indexed citations
18.
Xiong, Wei, Na Xu, Hanfeng Guan, et al.. (2017). Strontium-loaded titania nanotube arrays repress osteoclast differentiation through multiple signalling pathways: In vitro and in vivo studies. Scientific Reports. 7(1). 2328–2328. 46 indexed citations
19.
Guan, Hanfeng, Wei Wu, Zhong Fang, et al.. (2015). Decitabine represses osteoclastogenesis through inhibition of RANK and NF-κB. Cellular Signalling. 27(5). 969–977. 19 indexed citations
20.
Guan, Hanfeng, Bobin Mi, Zhong Fang, et al.. (2015). FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression. Oncogenesis. 4(9). e166–e166. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026